P16‐2: Development and assessment of the efficacy and safety of human lung‐targeting liposomal methylprednisolone crosslinked with nanobody
Respirology (Carlton, Vic.), 2021-11, Vol.26 (S3), p.448-448
[Periódico revisado por pares]
Chichester, UK: John Wiley & Sons, Ltd
Texto completo disponível
Página Inicial
RSS
Feed
Políticas
Fale Conosco
Logos de Redes Sociais: 